In Q2 2025, Hims & Hers reported adjusted earnings of $0.17 per share, topping estimates of $0.15. Revenue rose 73% year-over ...

We recently published 10 Stocks That Vanished in Value Hims & Hers Health, Inc. (NYSE:HIMS) is one of the worst-performing ...

Dudum is still the largest individual holder of Hims & Hers’ stock, with the latest Form 4 showing that he owned 8 million ...

Dudum offloaded shares totaling over $6.6 million in value, with transactions occurring on June 4, 2024. The CEO sold 119,049 shares at an average price of approximately $19.73 and another batch ...

Hims & Hers Health ( NYSE: HIMS) shares traded lower for the second straight session on Tuesday after the telehealth firm’s ...

On April 29, 2025, Hims & Hers and Novo Nordisk unveiled a landmark collaboration to bring Wegovy—Novo's blockbuster ...

Andrew Dudum, the CEO and 10% Owner of Hims & Hers Health Inc (NYSE:HIMS), has recently sold a significant number of shares in the company. On December 1, 2023, the insider executed a sale of 28,100 ...

Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a fortune off the popularity of weight loss injections.

Andrew Dudum, Chief Executive Officer of Hims & Hers Health, Inc. (NYSE:HIMS), has recently sold a significant amount of company stock, according to the latest SEC filings. Dudum offloaded shares ...

And hypocrite Dudum couldn’t get me up to buy his products if he paid me $200 million. Originally published as Go woke, go broke: Hims & Hers boss Andrew Dudum is a morally bankrupt Dud by name ...

Andrew Dudum is a disrupter. In 2017 he founded Hims & Hers (NYSE: HIMS), a digital health startup with the goal of upending the traditional healthcare market.